首页> 外国专利> MEDICINE FOR THERAPY OF HORMONE ABNORMALITY AT PRE-CLIMACTERIUM, HORMONE SUPPLY THERAPY AT CLIMACTERIUM, THERAPY FOR ANDROGEN INDUC- ING IMPEDIMENT AND BIRTH CONTROL

MEDICINE FOR THERAPY OF HORMONE ABNORMALITY AT PRE-CLIMACTERIUM, HORMONE SUPPLY THERAPY AT CLIMACTERIUM, THERAPY FOR ANDROGEN INDUC- ING IMPEDIMENT AND BIRTH CONTROL

机译:临孕前激素异常治疗的药物,足疗中激素供应治疗,雄激素诱导治疗和节育的药物

摘要

PURPOSE: To obtain the subject medicine containing dihydrospirorenone as an active ingredient. CONSTITUTION: This medicine contains dihydrospirorenone of the formula having a gestagen action, an antialdosterone action and a remarkable antiandrogen action as an active ingredient. The medicine advantageously contains an estrogen in addition to the compound of the formula. Ethynylestradiol or the other estrogen is preferably used, when an antifertility activity is preceded, and a natural estrogen is preferably used, when a surrogate action is preceded. The compound of the formula is administered at a daily dose of 0.5-50mg, preferably 1-10mg, and the estrogen is administered at a daily dose corresponding to 0.02-0.04mg of 17-ethynylestradiol or 0.4-40mg of estradiol.
机译:目的:获得含有二氢螺旋体酮作为有效成分的主题药物。组成:该药物含有具有孕激素作用,抗醛固酮作用和显着的抗雄激素作用的化学式的二氢螺螺酮作为有效成分。药物除了式的化合物之外还有利地包含雌激素。当先具有抗生育活性时,优选使用乙炔雌二醇或其他雌激素;当先进行替代作用时,优选使用天然雌激素。式的化合物以0.5-50mg,优选1-10mg的日剂量给药,雌激素以相当于0.02-0.04mg 17-乙炔基雌二醇或0.4-40mg雌二醇的日剂量给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号